These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18660993)

  • 1. TNF/TNFR1 signaling up-regulates CCR5 expression by CD8+ T lymphocytes and promotes heart tissue damage during Trypanosoma cruzi infection: beneficial effects of TNF-alpha blockade.
    Kroll-Palhares K; Silvério JC; Silva AA; Michailowsky V; Marino AP; Silva NM; Carvalho CM; Pinto LM; Gazzinelli RT; Lannes-Vieira J
    Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):375-85. PubMed ID: 18660993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
    Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
    Front Immunol; 2020; 11():306. PubMed ID: 32194558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis.
    Marino AP; da Silva A; dos Santos P; Pinto LM; Gazzinelli RT; Teixeira MM; Lannes-Vieira J
    Circulation; 2004 Sep; 110(11):1443-9. PubMed ID: 15337689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage.
    Medeiros GA; Silvério JC; Marino AP; Roffê E; Vieira V; Kroll-Palhares K; Carvalho CE; Silva AA; Teixeira MM; Lannes-Vieira J
    Microbes Infect; 2009 Feb; 11(2):264-73. PubMed ID: 19100857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Polymorphism at
    Batista AM; Alvarado-Arnez LE; Alves SM; Melo G; Pereira IR; Ruivo LAS; da Silva AA; Gibaldi D; da Silva TDESP; de Lorena VMB; de Melo AS; de Araújo Soares AK; Barros MDS; Costa VMA; Cardoso CC; Pacheco AG; Carrazzone C; Oliveira W; Moraes MO; Lannes-Vieira J
    Front Immunol; 2018; 9():615. PubMed ID: 29696014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming astrocytes with TNF enhances their susceptibility to Trypanosoma cruzi infection and creates a self-sustaining inflammatory milieu.
    Silva AA; Silva RR; Gibaldi D; Mariante RM; Dos Santos JB; Pereira IR; Moreira OC; Lannes-Vieira J
    J Neuroinflammation; 2017 Sep; 14(1):182. PubMed ID: 28877735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short treatment with the tumour necrosis factor-alpha blocker infliximab diminishes chronic chagasic myocarditis in rats without evidence of Trypanosoma cruzi reactivation.
    Pérez AR; Fontanella GH; Nocito AL; Revelli S; Bottasso OA
    Clin Exp Immunol; 2009 Aug; 157(2):291-9. PubMed ID: 19604269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline reverses chronic experimental Chagasic cardiomyopathy in association with repositioning of abnormal CD8+ T-cell response.
    Pereira IR; Vilar-Pereira G; Moreira OC; Ramos IP; Gibaldi D; Britto C; Moraes MO; Lannes-Vieira J
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003659. PubMed ID: 25789471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi.
    Machado FS; Koyama NS; Carregaro V; Ferreira BR; Milanezi CM; Teixeira MM; Rossi MA; Silva JS
    J Infect Dis; 2005 Feb; 191(4):627-36. PubMed ID: 15655788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CC-chemokine receptors: a potential therapeutic target for Trypanosoma cruzi-elicited myocarditis.
    Marino AP; Silva AA; Santos PV; Pinto LM; Gazinelli RT; Teixeira MM; Lannes-Vieira J
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():93-6. PubMed ID: 15962104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathy.
    Silverio JC; Pereira IR; Cipitelli Mda C; Vinagre NF; Rodrigues MM; Gazzinelli RT; Lannes-Vieira J
    PLoS Pathog; 2012; 8(4):e1002645. PubMed ID: 22532799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.
    Silverio JC; de-Oliveira-Pinto LM; da Silva AA; de Oliveira GM; Lannes-Vieira J
    Int J Exp Pathol; 2010 Feb; 91(1):72-86. PubMed ID: 19878357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy.
    Bilate AM; Salemi VM; Ramires FJ; de Brito T; Russo M; Fonseca SG; Faé KC; Martins DG; Silva AM; Mady C; Kalil J; Cunha-Neto E
    Microbes Infect; 2007 Jul; 9(9):1104-13. PubMed ID: 17644389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent production of inflammatory and anti-inflammatory cytokines and associated MHC and adhesion molecule expression at the site of infection and disease in experimental Trypanosoma cruzi infections.
    Zhang L; Tarleton RL
    Exp Parasitol; 1996 Nov; 84(2):203-13. PubMed ID: 8932770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-α is involved in the abnormal thymocyte migration during experimental Trypanosoma cruzi infection and favors the export of immature cells.
    Pérez AR; Berbert LR; Lepletier A; Revelli S; Bottasso O; Silva-Barbosa SD; Savino W
    PLoS One; 2012; 7(3):e34360. PubMed ID: 22461911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis.
    da Matta Guedes PM; Gutierrez FR; Maia FL; Milanezi CM; Silva GK; Pavanelli WR; Silva JS
    PLoS Negl Trop Dis; 2010 Feb; 4(2):e604. PubMed ID: 20169058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells responding to Trypanosoma cruzi detected by membrane TNF-α and CD154 in chagasic patients.
    Ripoll JG; Giraldo NA; Bolaños NI; Roa N; Rosas F; Cuéllar A; Puerta CJ; González JM
    Immun Inflamm Dis; 2018 Mar; 6(1):47-57. PubMed ID: 28967229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease.
    Pereira IR; Vilar-Pereira G; Silva AA; Moreira OC; Britto C; Sarmento ED; Lannes-Vieira J
    Mediators Inflamm; 2014; 2014():798078. PubMed ID: 25140115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TcVac3 induced control of Trypanosoma cruzi infection and chronic myocarditis in mice.
    Gupta S; Garg NJ
    PLoS One; 2013; 8(3):e59434. PubMed ID: 23555672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
    Pérez-Antón E; Egui A; Thomas MC; Puerta CJ; González JM; Cuéllar A; Segovia M; López MC
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006480. PubMed ID: 29750791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.